Cargando…

Therapy to target renal cell carcinoma using (131)I-labeled B7-H3 monoclonal antibody

B7-H3 is a tumor-associated antigen that plays a critical role in potential tumor-targeted therapy. In this study, we aimed to assess the radiobiological effect of (131)I-labeled B7-H3 monoclonal antibody ((131)I-4H7) in nude mice with human renal cell carcinoma (RCC) and evaluate the effect of (131...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Gongcheng, Wu, Ziyu, Wang, Yunyan, Li, Xueqin, Zhang, Guangbo, Hou, Jianquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029751/ https://www.ncbi.nlm.nih.gov/pubmed/27058890 http://dx.doi.org/10.18632/oncotarget.8550

Ejemplares similares

Localisation of gastrointestinal cancer with a 131 I labelled monoclonal antibody to CEA.
por: Allum, W. H., et al.
Publicado: (1986)

Radioimmunotherapy of transplanted small cell lung cancer with 131I-labelled monoclonal antibody.
por: Yoneda, S., et al.
Publicado: (1988)

Radioimmunotherapy for Pancreatic Carcinoma Using (131)I‐Labeled Monoclonal Antibody Nd2 in Xenografted Nude Mice
por: Inui, Akimasa, et al.
Publicado: (1996)

The treatment of intraperitoneal malignant disease with monoclonal antibody guided 131I radiotherapy.
por: Ward, B., et al.
Publicado: (1988)

Therapy of cervical cancer using (131)I-labeled nanoparticles
por: Li, Wei, et al.
Publicado: (2018)

Intrathecal administration of 131I radiolabelled monoclonal antibody as a treatment for neoplastic meningitis.
por: Moseley, R. P., et al.
Publicado: (1990)

Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.
por: Gerretsen, M., et al.
Publicado: (1992)

Expression and significance of B7-H3 and Tie-2 in the tumor vasculature of clear cell renal carcinoma
por: Zhang, Xianyun, et al.
Publicado: (2017)

Radioimmunotherapy of human hepatocellular carcinoma xenografts with 131I-labelled antiferritin antibody.
por: Saiful Alam, A. F.
Publicado: (1991)

Immunoscintigraphy of human lung squamous cell carcinoma using an iodine-131 labelled monoclonal antibody (Po66).
por: Bourguet, P., et al.
Publicado: (1990)

Evaluation of (131)I-Anti-Angiotensin II Type 1 Receptor Monoclonal Antibody as a Reporter for Hepatocellular Carcinoma
por: Hao, Pan-Pan, et al.
Publicado: (2014)

Prognostic value of B7-H3 expression in patients with solid tumors: a meta-analysis
por: Zhang, Xianyun, et al.
Publicado: (2017)

Pre-existing anti-mouse immunoglobulin in a patient receiving 131I-murine monoclonal antibody for radioimmunolocalisation.
por: Davies, A. G., et al.
Publicado: (1986)

Selective immunotherapy of small cell cancer xenografts using 131I-labelled SWA11 antibody.
por: Smith, A., et al.
Publicado: (1991)

B7-H3 Promotes Prostate Cancer Progression in Mice by Antagonizing Myeloid-Derived Suppressor Cell Apoptosis
por: Zhou, Yunfen, et al.
Publicado: (2020)

Evidence for a shared HLA-A intralocus determinant defined by monoclonal antibody 131
Publicado: (1985)

Treatment of recurrent and cystic malignant gliomas by a single intracavity injection of 131I monoclonal antibody: feasibility, pharmacokinetics and dosimetry.
por: Papanastassiou, V., et al.
Publicado: (1993)

Radioimmunotherapy study of (131)I-labeled Atezolizumab in preclinical models of colorectal cancer
por: Zhang, Linhan, et al.
Publicado: (2022)

Increased UCP1 expression in the perirenal adipose tissue of patients with renal cell carcinoma
por: Li, Xueqin, et al.
Publicado: (2019)

Multiple Modes of Action of a Monoclonal Antibody against Multidrug-Resistant Escherichia coli Sequence Type 131-H30
por: Guachalla, Luis M., et al.
Publicado: (2017)

Sequelae and survivorship in patients treated with (131)I-MIBG therapy
por: Sze, W C C, et al.
Publicado: (2013)

Different expression of B7-H3 in the caput, corpus, and cauda of the epididymis in mouse
por: Li, Kai, et al.
Publicado: (2017)

Radionuclide (131)I-labeled albumin-indocyanine green nanoparticles for synergistic combined radio-photothermal therapy of anaplastic thyroid cancer
por: Zhang, Xuemei, et al.
Publicado: (2022)

Effect of (131)I Therapy on Complete Blood Count in Patients with Differentiated Thyroid Cancer
por: Rui, Zhongying, et al.
Publicado: (2021)

A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer
por: Rossi, J-F, et al.
Publicado: (2010)

Thyroid Remnant Estimation by Diagnostic Dose (131) I Scintigraphy or (99m) T c O (4) (−) Scintigraphy after Thyroidectomy: A Comparison with Therapeutic Dose (131) I Imaging
por: Liu, Guanghui, et al.
Publicado: (2016)

A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients
por: Bleumer, I, et al.
Publicado: (2004)

Assessment of the efficacy and toxicity of (131)I-metaiodobenzylguanidine therapy for metastatic neuroendocrine tumours
por: Nwosu, A C, et al.
Publicado: (2008)

Phase I/II study of (131)I-MIBG with vincristine and 5 days of irinotecan for advanced neuroblastoma
por: DuBois, S G, et al.
Publicado: (2015)

Non-invasive imaging of Toll-like receptor 5 expression using (131)I-labeled mAb in the mice bearing H22 tumors
por: YANG, CHANGYA, et al.
Publicado: (2014)

Anti-metastatic effect of (131)I-labeled Buthus martensii Karsch chlorotoxin in gliomas
por: Wu, Shan, et al.
Publicado: (2018)

Immunohistochemical analysis of intratumoral heterogeneity of [131I]cG250 antibody uptake in primary renal cell carcinomas.
por: Steffens, M. G., et al.
Publicado: (1998)

Evaluation of an (131)I-labeled HER2-specific single domain antibody fragment for the radiopharmaceutical therapy of HER2-expressing cancers
por: Feng, Yutian, et al.
Publicado: (2022)

Radionuclide I-131 Labeled Albumin-Paclitaxel Nanoparticles for Synergistic Combined Chemo-radioisotope Therapy of Cancer
por: Tian, Longlong, et al.
Publicado: (2017)

Immunocytochemical Labelling of Haematological Samples Using Monoclonal Antibodies
por: Erber, Wendy N.
Publicado: (2021)

(131)I–Tositumomab in lymphoma
por: Cheung, M.C., et al.
Publicado: (2009)

Comparison of the efficacy and safety of URSL, RPLU, and MPCNL for treatment of large upper impacted ureteral stones: a randomized controlled trial
por: Wang, Yunyan, et al.
Publicado: (2017)

Radioiodination and Purification of [(131)I]β-CIT and [(131)I]FP-CIT with an Automated Radiosynthesizer
por: Plhak, Elisabeth, et al.
Publicado: (2022)

Biological Evaluation of (131)I- and CF750-Labeled Dmab(scFv)-Fc Antibodies for Xenograft Imaging of CD25-Positive Tumors
por: Fan, Qing, et al.
Publicado: (2014)

Radioimmunotherapy of metastatic colorectal tumours with iodine-131-labelled antibody to carcinoembryonic antigen: phase I/II study with comparative biodistribution of intact and F(ab')2 antibodies.
por: Lane, D. M., et al.
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_mgi2h8i901tes30ii273tolrjm